Penn Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Penn Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-39,685	Closed	-$2.22M	–	284
2017 Q4	$2.22M	Sell	39,685 -1,458	-4%	-$79.8K	0.16%	164
2017 Q3	$2.44M	Buy	41,143 +26,691	+185%	+$1.56M	0.18%	150
2017 Q2	$870K	Sell	14,452 -3,158	-18%	-$180K	0.06%	207
2017 Q1	$2.86M	Buy	+17,610	New	+$867K	0.2%	134

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Penn Capital Management's BIVV Position: Q1 2018 in Review

Penn Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 39,685 shares — an estimated $2.22M sold.

Penn Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.86M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Penn Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Penn Capital Management sold 39,685 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.22M.
Penn Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Penn Capital Management's Bioverativ Inc. Common Stock position peaked at $2.86M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Penn Capital Management's 13F filing for Q1 2018, filed 11 May 2018.